The pregnant mother with breast cancer: Diagnostic and therapeutic management
dc.contributor.author | Pavlidis, Nicholas | en |
dc.contributor.author | Pentheroudakis, George | en |
dc.creator | Pavlidis, Nicholas | en |
dc.creator | Pentheroudakis, George | en |
dc.date.accessioned | 2018-06-22T09:54:20Z | |
dc.date.available | 2018-06-22T09:54:20Z | |
dc.date.issued | 2005 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/42309 | |
dc.description.abstract | This review describes the epidemiology, pathology, clinical picture and therapeutic management of pregnant women with breast cancer. In addition, it covers other important issues like the safety of both diagnostic and treatment procedures, the indications for pregnancy termination, the mother and fetal outcome as well as the metastatic potential to the placenta and/or fetus. Several recommendations are also provided. © 2005 Elsevier Ltd. All rights reserved. | en |
dc.language.iso | eng | en |
dc.source | Cancer treatment reviews | en |
dc.subject | Antineoplastic agent | en |
dc.subject | Cisplatin | en |
dc.subject | Cyclophosphamide | en |
dc.subject | Doxorubicin | en |
dc.subject | Etoposide | en |
dc.subject | Fluorouracil | en |
dc.subject | Human | en |
dc.subject | Methotrexate | en |
dc.subject | Humans | en |
dc.subject | Breast neoplasms | en |
dc.subject | Female | en |
dc.subject | Mammography | en |
dc.subject | Paclitaxel | en |
dc.subject | Alopecia | en |
dc.subject | Drug safety | en |
dc.subject | Fatigue | en |
dc.subject | Febrile neutropenia | en |
dc.subject | Navelbine | en |
dc.subject | Neutropenia | en |
dc.subject | Ondansetron | en |
dc.subject | Nephrotoxicity | en |
dc.subject | Cancer staging | en |
dc.subject | Cardiotoxicity | en |
dc.subject | Granulocyte colony stimulating factor | en |
dc.subject | Review | en |
dc.subject | Docetaxel | en |
dc.subject | Fetus | en |
dc.subject | Neoplastic | en |
dc.subject | Pregnancy | en |
dc.subject | Pregnancy complications | en |
dc.subject | Antibiotic agent | en |
dc.subject | Dose response | en |
dc.subject | Hematologic malignancy | en |
dc.subject | Pancytopenia | en |
dc.subject | Pregnancy complication | en |
dc.subject | Teratogenicity | en |
dc.subject | Bisphosphonic acid derivative | en |
dc.subject | Epirubicin | en |
dc.subject | Melanoma | en |
dc.subject | Trastuzumab | en |
dc.subject | Clinical feature | en |
dc.subject | Vomiting | en |
dc.subject | Breast cancer | en |
dc.subject | Histopathology | en |
dc.subject | Lymph node dissection | en |
dc.subject | Mastectomy | en |
dc.subject | Nausea | en |
dc.subject | Cytotoxic agent | en |
dc.subject | Bone marrow toxicity | en |
dc.subject | Treatment | en |
dc.subject | Alkylating agent | en |
dc.subject | Antimetabolite | en |
dc.subject | Vinca alkaloid | en |
dc.subject | Multimodality cancer therapy | en |
dc.subject | Anthracycline | en |
dc.subject | Treatment indication | en |
dc.subject | Erythropoietin | en |
dc.subject | Diagnostic imaging | en |
dc.subject | Echomammography | en |
dc.subject | Metoclopramide | en |
dc.subject | Metastasis potential | en |
dc.subject | Gadolinium | en |
dc.subject | Fetotoxicity | en |
dc.subject | Fetus malformation | en |
dc.subject | Placenta disorder | en |
dc.subject | Breast biopsy | en |
dc.subject | Diagnosis staging | en |
dc.subject | Drug metabolism | en |
dc.subject | Fetoplacental unit | en |
dc.subject | Growth disorder | en |
dc.subject | Haloperidol | en |
dc.subject | Hearing loss | en |
dc.subject | Lactation | en |
dc.subject | Low birth weight | en |
dc.subject | Placental/fetal metastases | en |
dc.subject | Pregnancy outcome | en |
dc.subject | Pregnancy termination | en |
dc.subject | Preoperative evaluation | en |
dc.subject | Radiation carcinogenesis | en |
dc.title | The pregnant mother with breast cancer: Diagnostic and therapeutic management | en |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | 10.1016/j.ctrv.2005.04.010 | |
dc.description.volume | 31 | |
dc.description.issue | 6 | |
dc.description.startingpage | 439 | |
dc.description.endingpage | 447 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Pavlidis, Nicholas [0000-0002-2195-9961] | |
dc.contributor.orcid | Pentheroudakis, George [0000-0002-6632-2462] | |
dc.gnosis.orcid | 0000-0002-2195-9961 | |
dc.gnosis.orcid | 0000-0002-6632-2462 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |